Diabetes & Metabolism Journal

Reviews

Lifestyle and Behavioral Interventions
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions: Matthew J. Savage, Jonathan Goldney, Tommy Slater, Priscilla Sarkar, Jack A. Sargeant, Emma G. Wilmot, Melanie J. Davies; Diabetes Metab J. 2025;49(5):934-950. Published online September 1, 2025; DOI: https://doi.org/10.4093/dmj.2025.0561

5,710 View
307 Download
1 Web of Science
1 Crossref

The global prevalence of early-onset type 2 diabetes (EOT2D) is rising rapidly. Adults with EOT2D represent a high-risk population characterised by increased rates of microvascular and macrovascular complications, adverse psychological wellbeing and psychiatric comorbidities such as depression, and premature mortality compared to those with later-onset type 2 diabetes mellitus. This emerging population faces unique challenges, including high levels of diabetes-related stigma, clinical inertia, and competing life demands, such as starting a family. This review synthesises current evidence on the clinical management of EOT2D. Key therapeutic targets include weight reduction, preservation of β-cell function, cardiometabolic risk management, and psychological support. Overall, there are few randomized controlled trials (RCTs) undertaken specifically in adults with EOT2D. However, we summarise early data from the few RCTs that do report outcomes specific in young adults, with bariatric surgery, tirzepatide and intensive lifestyle interventions emerging as particularly effective treatments. There is a strong rationale that technology-based inventions and structured education programs may prove to be effective treatments but data from RCTs is lacking. We provide broad recommendations for future research and clinical practice based on the current evidence. In conclusion, substantial further research is required to inform tailored, evidence-based guidelines and improve long-term outcomes in this underserved population.

Citations

Citations to this article as recorded by

Identification of oral microbial biomarkers for prediabetes in young adults: A two-stage population-based study
Jiaqi Li, Guishao Tang, Zhiguo Xie, Lin Yang, Zhiguang Zhou, Keyu Guo
Diabetes Research and Clinical Practice.2026; 232: 113101. CrossRef

Lifestyle
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies: Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, Elena S. George, Melkamu T. Hunegnaw, Costas Glavas, Paul Jansons, Robin M. Daly, David Scott; Diabetes Metab J. 2023;47(6):719-742. Published online September 14, 2023; DOI: https://doi.org/10.4093/dmj.2023.0112

30,349 View
989 Download
49 Web of Science
54 Crossref

Abstract PDF PubReader ePub

Type 2 diabetes mellitus (T2DM) and sarcopenia (low skeletal muscle mass and function) share a bidirectional relationship. The prevalence of these diseases increases with age and they share common risk factors. Skeletal muscle fat infiltration, commonly referred to as myosteatosis, may be a major contributor to both T2DM and sarcopenia in older adults via independent effects on insulin resistance and muscle health. Many strategies to manage T2DM result in energy restriction and subsequent weight loss, and this can lead to significant declines in muscle mass in the absence of resistance exercise, which is also a first-line treatment for sarcopenia. In this review, we highlight recent evidence on established treatments and emerging therapies targeting weight loss and muscle mass and function improvements in older adults with, or at risk of, T2DM and/or sarcopenia. This includes dietary, physical activity and exercise interventions, new generation incretin-based agonists and myostatin-based antagonists, and endoscopic bariatric therapies. We also highlight how digital health technologies and health literacy interventions can increase uptake of, and adherence to, established and emerging treatments and therapies in older adults with T2DM and/or sarcopenia.

Citations

Citations to this article as recorded by

Phosphoglycerate kinase 1 as a potential biomarker and therapeutic target for diabetic sarcopenia
Fangyu Li, Qingsheng Wang, Rui Li, Yuanyuan Gao, Ying Wang, Qi Chen
QJM: An International Journal of Medicine.2026; 119(1): 23. CrossRef
Comparing bone and muscle parameters in community-dwelling older adults with obesity, with or without type 2 diabetes mellitus
Costas Glavas, Jakub Mesinovic, Peter R. Ebeling, Surbhi Sood, Elena S. George, Melkamu Tamir Hunegnaw, Ayse Zengin, Robin M. Daly, Paul Jansons, David Scott
Bone.2026; 202: 117680. CrossRef
Prevalence and risk factors of sarcopenia in Asian adults with type 2 diabetes: A systematic review and meta‐analysis
Yueh‐Chu Wu, Man‐Ting Mao, Hung‐En Huang, Chien‐Ning Huang, Wen‐Chun Liao
Journal of Diabetes Investigation.2026; 17(1): 83. CrossRef
Sarcopenia and MASLD: novel insights and the future
Chang-Hai Liu, Qing-Min Zeng, Won Kim, Seung Up Kim, Zobair M. Younossi, Giovanni Targher, Christopher D. Byrne, Christos S. Mantzoros, Phunchai Charatcharoenwitthaya, Isabelle Anne Leclercq, Manuel Romero-Gómez, Hong Tang, Ming-Hua Zheng
Nature Reviews Endocrinology.2026; 22(3): 139. CrossRef
Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: A multi-omics and Mendelian Randomization study
Shuxu Wei, Zhouwu Shu, Xinyi Li, Suiqin Zhong, Ling Xiao, Ronghuai Shen, Xiaojia Lu, Lingbin He, Youti Zhang, Yan Quan, Xianxi Huang
Metabolism.2026; 175: 156452. CrossRef
Ageing of human myofibres in the Vastus Lateralis muscle: A narrative review
Antoneta Granic, Davina C.M. Simoes, T. Scott Bowen, Nessrin Almaghtuf, Gavin Richardson, Avan A. Sayer
Ageing Research Reviews.2026; 115: 103022. CrossRef
Assessment of screening tools for diabetic sarcopenia in type 2 diabetes mellitus: evidence from a scoping review
Jiawei Yin, Xiaotu Zhang, Jing Cai, Hongshi Zhang, Xuefeng Sun, Zilin Wang, Ye Zhang, Lin Li
Frontiers in Endocrinology.2026;[Epub] CrossRef
Body composition and bone mineral density in patients with type 2 diabetes mellitus and sarcopenia
Mo Li, Qing Zhao
International Journal of Diabetes in Developing Countries.2026;[Epub] CrossRef
How Pragmatic Are Sarcopenia Intervention Studies? A Systematic Review
Sophie Van Heden, Zoubayda Baoubbou, Dolores Sanchez‐Rodriguez, Yoke Mun Chan, Charlotte Beaudart
Journal of Cachexia, Sarcopenia and Muscle.2026;[Epub] CrossRef
Exercise, Exerkines, and Sarcopenia
Hye Soo Chung, Kyung Mook Choi
Diabetes & Metabolism Journal.2026; 50(1): 19. CrossRef
Development and validation of a machine learning-based sarcopenia prediction model using the triglyceride glucose–frailty index
Wang Xiang, Houcheng Zhu, Xiandong Liu, Qingsong Wu
Journal of International Medical Research.2026;[Epub] CrossRef
Association between weight-adjusted waist index and the incidence of low back pain among middle-aged and older adults: a nationwide prospective cohort study in China
Xiujie Meng, Wenlong Yu, Junming Ma
European Spine Journal.2026;[Epub] CrossRef
Investigation of the Relationship Between Glycemic Control and Inflammation–Nutrition Indices in Older Adults with Type 2 Diabetes
Feyza Mutlay, Murat Das, Merve Durmaz Yıldız, Ferhan Demirer Aydemir, Ece Ünal Çetin, Özge Kurtkulağı
Medicina.2026; 62(2): 369. CrossRef
Type 1 diabetes, ageing and frailty: an underexplored intersection
Giuseppe Maltese, Janaka Karalliedde, Jugdeep Dhesi, Srikanth Bellary
Diabetologia.2026;[Epub] CrossRef
Higher body mass index increases the risk of shoulder adhesive capsulitis in young adults: a nationwide cohort study
Jong-Ho Kim, Jae-Yoon Baek, Kyung-Do Han, Bong-Seoung Kim, Hyuk-Sang Kwon
Journal of Shoulder and Elbow Surgery.2025; 34(1): 26. CrossRef
Unraveling the dual threat: sarcopenia and insufficient physical activity in diabetes risk
Hui Shi
Frontiers in Endocrinology.2025;[Epub] CrossRef
Molecular insights into Parkinson's disease and type 2 diabetes mellitus: Metformin's role and genetic pathways explored
Tingting Liu, Haojie Wu, Jianshe Wei
Experimental Neurology.2025; 385: 115137. CrossRef
Relationship between Muscle Mass by Bioimpedance and Vascular Complications in Type 2 Diabetes Mellitus
Alejandra Calderón, Cristina Arteaga, Elizabeth Quiroga, Lisbeth Reales, Marcelo Pilamunga, Fernanda Marizande, Alberto Bustillos
Salud, Ciencia y Tecnología.2025;[Epub] CrossRef
Impact of socioeconomic status on utilisation of a Virtual Emergency Department: An exploratory analysis
Jason Talevski, Shady Rizk, Loren Sher, Rebecca L Jessup, Adam I Semciw, James H Boyd, Suzanne M Miller, Jennie Hutton
Emergency Medicine Australasia.2025;[Epub] CrossRef
Risk factors for sarcopenia in community setting across the life course: A systematic review and a meta-analysis of longitudinal studies
Yajing Gao, Yuli Huang, Ran An, Yi Yang, Xinyao Chen, Qiaoqin Wan
Archives of Gerontology and Geriatrics.2025; 133: 105807. CrossRef
Development and validation of a predictive model for the risk of possible sarcopenia in middle-aged and older adult diabetes mellitus in China
Mengyuan Qiao, Haiyan Wang, Mengzhen Qin, Taohong Xing, Yingyang Li
Frontiers in Public Health.2025;[Epub] CrossRef
Primary Hyperparathyroidism: An Analysis Amid the Co-Occurrence of Type 2 Diabetes Mellitus
Ana-Maria Gheorghe, Mihaela Stanciu, Claudiu Nistor, Ioana Codruta Lebada, Mara Carsote
Life.2025; 15(4): 677. CrossRef
A comparative analysis of sarcopenia screening methods in Thai people with type 2 diabetes mellitus in an outpatient setting
Ornpicha Laohajaroensombat, Thanapat Limpaarayakul, Nattapol Sathavarodom, Apussanee Boonyavarakul, Parinya Samakkarnthai
BMC Geriatrics.2025;[Epub] CrossRef
Exercise and dietary recommendations to preserve musculoskeletal health during weight loss in adults with obesity: A practical guide
Jakub Mesinovic, Christopher Hurst, Gloria K. W. Leung, Jack R. Ryan, Robin M. Daly, David Scott
Reviews in Endocrine and Metabolic Disorders.2025; 26(5): 785. CrossRef
Exploring the link between age at menarche, anthropometry and body fat composition with type II diabetes in a Singapore multi-ethnic cohort
Paula Benny, Qian Yang, Beverly Wen-Xin Wong, Cuilin Zhang, Eu-Leong Yong, Ling-Jun Li, Zhongwei Huang
BMC Medicine.2025;[Epub] CrossRef
Current status of older people with chronic diseases adopting digital health technologies: A scoping review
Chengjin Li, Hansong Wang, Jiajun Yuan, Lili Shi, Yunhao Chen, Zefang Gao, Liebin Zhao, Abilio Oliveira
DIGITAL HEALTH.2025;[Epub] CrossRef
САРКОПЕНІЯ У ПАЦІЄНТІВ ІЗ ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ: СУЧАСНІ ДІАГНОСТИЧНІ КРИТЕРІЇ, МЕХАНІЗМИ РОЗВИТКУ ТА СТРАТЕГІЇ ЛІКУВАННЯ
Лариса Журавльова, Олена Кривоносова, Анна Журавльова
PROBLEMS OF ENDOCRINE PATHOLOGY.2025; 82(2): 54. CrossRef
Mediation effects of age, intramuscular adipose tissue index and serum albumin on survival status in initial dialysis patients
Meng-huan Wu, Yu-ting Gao, Yu-xin Ren, Wen Zhou, Jing Zheng, Shi-mei Hou, Yao Wang, Jing-yuan Cao, Xiao-xu Wang, Yan Yang, Bin Wang, Min Yang, Jing-ting Jiang, Min Li
Renal Failure.2025;[Epub] CrossRef
Associations of circulating apolipoprotein J and myostatin with sarcopenia in older adults with and without type 2 diabetes: a cross-sectional study
Inha Jung, Da-Hye Shin, Hyun Joo Cho, So Young Park, Da Young Lee, Ji Hee Yu, Nan Hee Kim, Minjin Lee, Young-Bum Kim, Ji A Seo
Frontiers in Endocrinology.2025;[Epub] CrossRef
Therapeutic advances in sarcopenia management: From traditional interventions to personalized medicine
Xiangliang Liu, Xinqiao Chen, Jiuwei Cui
Clinical Nutrition.2025; 51: 187. CrossRef
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP‐1 Agonists: A Literature Review
Jimmy Wen, Ubaid Ansari, Mouhamad Shehabat, Zaid Ansari, Burhaan Syed, Adam Razick, Daniel Razick, Muzammil Akhtar, Eldo Frezza
Journal of Diabetes.2025;[Epub] CrossRef
Effects of Blood-Glucose Lowering Therapies on Body Composition and Muscle Outcomes in Type 2 Diabetes: A Narrative Review
Ioana Bujdei-Tebeică, Doina Andrada Mihai, Anca Mihaela Pantea-Stoian, Simona Diana Ștefan, Claudiu Stoicescu, Cristian Serafinceanu
Medicina.2025; 61(8): 1399. CrossRef
Vitamin D and Sarcopenia: Implications for Muscle Health
Héctor Fuentes-Barría, Raúl Aguilera-Eguía, Lissé Angarita-Davila, Diana Rojas-Gómez, Miguel Alarcón-Rivera, Olga López-Soto, Juan Maureira-Sánchez, Valmore Bermúdez, Diego Rivera-Porras, Julio Cesar Contreras-Velázquez
Biomedicines.2025; 13(8): 1863. CrossRef
Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies
Anamaria Andreea Danciu, Cornelia Bala, Georgeta Inceu, Camelia Larisa Vonica, Adriana Rusu, Gabriela Roman, Dana Mihaela Ciobanu
International Journal of Molecular Sciences.2025; 26(15): 7574. CrossRef
Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis
Qing Yang, Chunmei Qin, Yanlin Lang, Wenjie Yang, Fenghao Yang, Jia Yang, Ke Liu, Jiamin Yuan, Yutong Zou, Fang Liu
Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2885. CrossRef
Understanding the Role of Sarcopenia and Diet in Diabetes-Related Mortality
Wonjin Kim
CardioMetabolic Syndrome Journal.2025; 5(2): 112. CrossRef
Comparison of SGLT-2i and GLP-1RA on cardiovascular and renal outcomes in elderly patients with T2DM: a single-center retrospective cohort study
Yawei Qin, Xvguang Xv, Liang Cheng, Bin Liu
International Urology and Nephrology.2025; 58(3): 989. CrossRef
The association between living habits, physical activity level and sarcopenia in chinese older adults with type 2 diabetes mellitus: a cross-sectional study
Yiting Yue, Huaping Shen, Hongmei Li, Yongjing Zhang, Yiwei Zhao, Rui Zhang, Xiaoyan Xue
Frontiers in Public Health.2025;[Epub] CrossRef
High “sarcopenia index” reduce all-cause mortality in patients with acute myocardial infarction
Hui Pan, C. Yu Dong, Z. Cheng Yang, Y. Bin Xi, He Lin, J. Lu Zhu, X. Wen Wang, H. Jie Zhan, Z. Hao Wang
Clinical Nutrition.2025; 54: 91. CrossRef
Myosteatosis and Type 2 Diabetes Mellitus
Lucian Batista de Oliveira, Vanessa de Oliveira e Silva, Ítalo Caio Lopes Jucá, João Victor Gonçalves dos Santos Torres, Maria Roseneide dos Santos Torres, Fabio Moura, Francisco Bandeira
Acta Medica (Hradec Kralove, Czech Republic).2025; 68(2): 37. CrossRef
Association between Cardiovascular-Kidney-Metabolic Syndrome and Relative Muscle Loss in American Adults
Cheng-Di Yuan, Bo-Shui Huang, Zhong-Peng Li, Ji-Wei Zhao, Yao-Wei Zhi
International Heart Journal.2025; 66(6): 925. CrossRef
Epigenetic silencing of MSTN via m6A modification underlies the renoprotective effects of engineered MSC exosomes with RBM15 depletion in diabetic nephropathy
Qianlan Dong, Longhao Dong, Yanting Zhu, Xiaoming Wang, Xiaohui Yan
Functional & Integrative Genomics.2025;[Epub] CrossRef
End-Users’ Perspectives on Implementation Outcomes of Digital Voice Assistants Delivering a Home-Based Lifestyle Intervention in Older Obese Adults with Type 2 Diabetes Mellitus: A Qualitative Analysis
Costas Glavas, Jiani Ma, Surbhi Sood, Elena S. George, Robin M. Daly, Eugene Gvozdenko, Barbora de Courten, David Scott, Paul Jansons
Technologies.2025; 13(11): 511. CrossRef
Current Strategies for Healthy Aging: The Interplay Between Nutrition, Metabolism, and Exercise
Ana Matos, Cezara Tihon, Carolina Costa, Catarina Domingues
Cureus.2025;[Epub] CrossRef
Is the experience of chronic pain different in frail older adults? A cross-sectional exploratory study
Nayara Tasse de Oliveira Cirino, Marcos Paulo Miranda de Aquino, Camila Astolphi Lima, Fânia Cristina dos Santos, Mauricio de Miranda Ventura, Monica Rodrigues Perracini
Arquivos de Neuro-Psiquiatria.2025; 83(10): 001. CrossRef
Ophiopogon japonicus Root Extract Attenuates Obesity-Induced Muscle Atrophy Through Regulation of the PI3K-AKT-mTOR/FoxO3a Signaling Pathway and Lipid Metabolism in Mice and C2C12 Myotubes
Yang Wang, Haifeng Shao, Chenzi Lyu, Kyung Hee Park, Tran Khoa Nguyen, In Jun Yang, Hyo Won Jung, Yong-Ki Park
Nutrients.2025; 17(24): 3946. CrossRef
Clinical Nutrition Strategies for the Prevention and Management of Sarcopenia in Older Adults with Type 2 Diabetes
Sohye Kim
The Journal of Korean Diabetes.2025; 26(4): 238. CrossRef
Fucoidan ameliorates diabetic skeletal muscle atrophy through PI3K/Akt pathway
Caixia Li, Yaping Liu, Mingzhi Yang, Haoyue Huang, Lulu Tang, Yufan Miao, Wenjie Li, Xing Li
Journal of Functional Foods.2024; 114: 106076. CrossRef
Evaluation of the effect of testosterone replacement therapy with a transdermal testosterone on glycemic control in men with type 2 diabetes mellitus
R. V. Rozhivanov, M. O. Chernova, V. A. Ioutsi, G. A. Mel’nichenko, M. V. Shestakova, E. R. Rozhivanova, E. N. Andreeva, N. G. Mokrysheva
Diabetes mellitus.2024; 27(2): 120. CrossRef
Higher dietary live microbe intake is associated with a lower risk of sarcopenia
Kemin Yan, Xiaoyi Ma, Chen Li, Xiang Zhang, Manxuan Shen, Sai Chen, Jia Zhao, Wen He, Hua Hong, Yingying Gong, Gang Yuan
Clinical Nutrition.2024; 43(7): 1675. CrossRef
d-Pinitol Improves Diabetic Sarcopenia by Regulation of the Gut Microbiome, Metabolome, and Proteome in STZ-Induced SAMP8 Mice
Xin Yu, Pei Li, Baoying Li, Fei Yu, Wenqian Zhao, Xue Wang, Yajuan Wang, Haiqing Gao, Mei Cheng, Xiaoli Li
Journal of Agricultural and Food Chemistry.2024; 72(25): 14466. CrossRef
Proteomics Analysis Provides Insights into the Role of Lipid Metabolism in T2DM-Related Sarcopenia
Jingying Wu, Shengnan Wang, Huafeng Zhuang, Weichun Wang, Yaoguo Wang, Youfang Chen, Zhengping Huang, Chunnuan Chen, Xiaofeng Chen
ACS Omega.2024; 9(31): 34056. CrossRef
Age- and sex-dependent associations between self-reported physical activity levels and self-reported cardiovascular risk factors: a population-based cross-sectional survey
Johannes Burtscher, Martin Kopp, Jeannette Klimont, Hanno Ulmer, Barbara Strasser, Martin Burtscher
BMC Public Health.2024;[Epub] CrossRef
Addressing broader dietary patterns and physical activity in the study of dietary live microbe intake and sarcopenia
Chun-Yu Shen, Chen-Pi Li, Hui-Chin Chang, Shuo-Yan Gau
Clinical Nutrition.2024; 43(10): 2388. CrossRef

Guideline/Fact Sheet
Comprehensive Understanding for Application in Korean Patients with Type 2 Diabetes Mellitus of the Consensus Statement on Carbohydrate-Restricted Diets by Korean Diabetes Association, Korean Society for the Study of Obesity, and Korean Society of Hypertension: Jong Han Choi, Jee-Hyun Kang, Suk Chon; Diabetes Metab J. 2022;46(3):377-390. Published online May 25, 2022; DOI: https://doi.org/10.4093/dmj.2022.0051

11,111 View
306 Download
4 Web of Science
4 Crossref

Abstract PDF PubReader ePub

The Joint Committee of the Korean Diabetes Association, the Korean Society for the Study of Obesity, and the Korean Society of Hypertension announced a consensus statement on carbohydrate-restricted diets and intermittent fasting, representing an emerging and popular dietary pattern. In this statement, we recommend moderately-low-carbohydrate or low-carbohydrate diets, not a very-low-carbohydrate diet, for patients with type 2 diabetes mellitus. These diets can be considered a dietary regimen to improve glycemic control and reduce body weight in adults with type 2 diabetes mellitus. This review provides the detailed results of a meta-analysis and systematic literature review on the potential harms and benefits of carbohydrate-restricted diets in patients with diabetes. We expect that this review will help experts and patients by fostering an in-depth understanding and appropriate application of carbohydrate-restricted diets in the comprehensive management of diabetes.

Citations

Citations to this article as recorded by

The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of randomized controlled trials
Wende Tian, Shuyu Cao, Yongxin Guan, Zihao Zhang, Qiyu Liu, Jianqing Ju, Ruixi Xi, Ruina Bai
Frontiers in Nutrition.2025;[Epub] CrossRef
Efficacy of convenience meal-type foods designed for diabetes in the management of metabolic syndrome based on a 3-week trial
Do Gyeong Lee, In Gyeong Kang, Tae Seok Kim, Yun Ahn, Sang Yun Lee, Hye Jin Ahn, Yoo Kyoung Park
Nutrition.2024; 118: 112287. CrossRef
Long-Term Results of a Digital Diabetes Self-Management and Education Support Program Among Adults With Type 2 Diabetes: A Retrospective Cohort Study
Ashley Berthoumieux, Sarah Linke, Melinda Merry, Alison Megliola, Jessie Juusola, Jenna Napoleone
The Science of Diabetes Self-Management and Care.2024; 50(1): 19. CrossRef
Medical nutrition therapy for diabetes mellitus
Suk Chon
Journal of the Korean Medical Association.2023; 66(7): 421. CrossRef

Drug/Regimen
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs: Jang Won Son, Sungrae Kim; Diabetes Metab J. 2020;44(6):802-818. Published online December 23, 2020; DOI: https://doi.org/10.4093/dmj.2020.0258

31,815 View
1,430 Download
107 Web of Science
115 Crossref

Abstract PDF PubReader ePub

Obesity is among the leading causes of morbidity and mortality worldwide and its prevalence continues to increase globally. Because obesity is a chronic, complex, and heterogeneous disease influenced by genetic, developmental, biological, and environmental factors, it is necessary to approach obesity with an integrated and comprehensive treatment strategy. As it is difficult to achieve and sustain successful long-term weight loss in most patients with obesity through lifestyle modifications (e.g., diet, exercise, and behavioral therapy), pharmacological approaches to the treatment of obesity should be considered as an adjunct therapy. Currently, four drugs (orlistat, naltrexone extended-release [ER]/bupropion ER, phentermine/topiramate controlled-release, and liraglutide) can be used long-term (>12 weeks) to promote weight loss by suppressing appetite or decreasing fat absorption. Pharmacotherapy for obesity should be conducted according to a proper assessment of the clinical evidence and customized to individual patients considering the characteristics of each drug and comorbidities associated with obesity. In this review, we discuss the mechanisms of action, efficacy, and safety of these available long-term anti-obesity drugs and introduce other potential agents under investigation. Furthermore, we discuss the need for research on personalized obesity medicine.

Citations

Citations to this article as recorded by

Adipose-precise delivery of microwave-derived soybean lecithin-polypyrrole nano-pufferfish-shaped nanoparticle for localized NIR-photothermal therapy in managing obesity
Chih-Kuang Chen, Shen-Han Wu, Hsien-Tsung Lu, Hieu Trung Nguyen, Pin-Yen Lin, Wen-Yu Pan, Ke-Hung Tsui, Andrew E.-Y. Chuang
Biomaterials Advances.2026; 179: 214508. CrossRef
The Impact of Bariatric Surgery on the Development and Progression of Dermatologic Diseases: A Narrative Review
Mateusz Matwiejuk, Hanna Myśliwiec, Agnieszka Mikłosz, Adrian Chabowski, Iwona Flisiak
Dermatology and Therapy.2026; 16(1): 171. CrossRef
Pancreatic Lipase Inhibitors as Therapeutic Agents for Metabolic Disorders: Advances in Molecular Biology and Biotechnology: A Review
Othman A. Alghamdi
Industrial Biotechnology.2026; 22(1): 51. CrossRef
Vitisin A Regulates Lipid Metabolism in 3T3‐L1 Adipocytes and High‐Fat Diet‐Induced Obese Mice
Fangfang Tie, Na Hu, Qi Dong, Honglun Wang
Phytotherapy Research.2026; 40(1): 286. CrossRef
Obesity medications and acquired hypothalamic obesity in adults: A two-case experience
Henry Lang, Madisen F. Dorand, Mahnooor Hassan, Jesse R. Richards
Obesity Pillars.2026; 17: 100246. CrossRef
Beyond metabolism: sexual dysfunction and weight-loss drugs
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Jeny J Mendoza-Godoy, Luis Concepción-Urteaga, José Paz-Ibarra, Julia C Coronado-Arroyo
Sexual Medicine Reviews.2026;[Epub] CrossRef
Efficacy and Safety of Steamed Ginger Extract for Body Weight and Body Fat Reduction in Overweight Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Jeong Eun Kwon, Yeong-Geun Lee, Inhye Kim, Jaewoo Bae, Se-Chan Kang, Hyang-Im Baek
Nutrients.2026; 18(2): 366. CrossRef
Ensuring the Appropriate Use of Glucagon‐Like Peptide‐1 Receptor Agonists
Kenneth Todd Moore, Aman Gupta, Jinshan Shen, Parag Kumar
The Journal of Clinical Pharmacology.2025; 65(2): 153. CrossRef
A review on drug repurposing applicable to obesity
Feng Chen, Kai Jing, Zhen Zhang, Xia Liu
Obesity Reviews.2025;[Epub] CrossRef
Unraveling the Anti-Obesity Potential of Luteolin: Mechanistic Insights
Akhil Sharma, Gagandeep Kaur, Amandeep Kaur, Sushma Devi
Current Nutrition & Food Science.2025; 21(3): 295. CrossRef
Lipid nanosystems for fatty liver therapy and targeted medication delivery: a comprehensive review
Chuipeng Liang, Xing Liu, Zihao Sun, Lin Wen, Jijiao Wu, Sanjun Shi, Xiaolian Liu, Nini Luo, Xiaofang Li
International Journal of Pharmaceutics.2025; 669: 125048. CrossRef
Efficacy of phentermine/topiramate extended release in weight management and metabolic profiles: A multicentre study in South Korea
Kyoung Min Kim, Jong Han Choi, Byoungduck Han, Yang‐Im Hur, Jang Won Son, Ga Eun Nam, Jee‐Hyun Kang, Yoon Jeong Cho, Won Jun Kim, Soo Lim
Diabetes, Obesity and Metabolism.2025; 27(6): 3252. CrossRef
Microneedle-Mediated Treatment of Obesity
Huanhuan Pan, Wanshan Hu, Chunxian Zhou, Jubo Jian, Jing Xu, Chao Lu, Guilan Quan, Chuanbin Wu, Xin Pan, Tingting Peng
Pharmaceutics.2025; 17(2): 248. CrossRef
Early overfeeding and adult anhedonia: Impact of neonatal nutrition on hedonic food regulation in male rats
Pamela Rocío Fernández, Luisa Gaydou, Rocío Schumacher, María Florencia Rossetti, Ana Paula García, Agustina Sabella, Jorge Guillermo Ramos, Guillermina Canesini, Cora Stoker
The Journal of Nutritional Biochemistry.2025; 143: 109933. CrossRef
A Novel Supramolecular Salt of Hypoxanthine with Maleic Acid as a Potential Weight-Loss Drug
Fumin Xue, Xinyue Yuan, Xingyi Li, Shimin Fang, Yan Cheng
International Journal of Molecular Sciences.2025; 26(9): 4266. CrossRef
Integrating network pharmacology, quantitative transcriptomic analysis, and experimental validation revealed the mechanism of cordycepin in the treatment of obesity
Yu Liao, Mingchao Wang, Fuli Qin, Taotao Liu, Jiemei Chen
Frontiers in Pharmacology.2025;[Epub] CrossRef
Low molecular weight fucoidan: Production methods and their therapeutic applications
Rasika Gunarathne, Chunyang Zhang, Jinrong Zhou, Xuegang Xin, Jun Lu
International Journal of Biological Macromolecules.2025; 318: 145309. CrossRef
Curcumin alleviates visceral adiposity via inhibiting GIP release from hypoxic intestinal damage in MASH rats
Yingyi Liao, Xingyu Xie, Zixin Lin, Ning Huang, Guilan Wei, Jiazhen Wu, Yucui Li, Jiannan Chen, Ziren Su, Xiuting Yu, Liping Chen, Yuhong Liu
npj Science of Food.2025;[Epub] CrossRef
Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response
Jesús Argente, Karine Clément, Jessica Duis, I. Sadaf Farooqi, Peter Kühnen, Jennifer L. Miller, Christian L. Roth, Erica van den Akker
Reviews in Endocrine and Metabolic Disorders.2025; 26(6): 917. CrossRef
A review of anti-obesity medications and anaesthesia
KG Gordon, GA Horsten, CI Botha
Southern African Journal of Anaesthesia and Analgesia.2025; 31(3): 90. CrossRef
Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity
Hanneke M van Santen, Hermann L Müller
Endocrine Reviews.2025; 46(6): 891. CrossRef
Pharmacological and psychosocial interventions for night eating syndrome in adults
Lucas Ribeiro dos Santos, Márcio Luís Duarte, Virgínia Fernandes Moça Trevisani, Maria Stella Peccin, Tamara Melnik
Frontiers in Psychiatry.2025;[Epub] CrossRef
The Gut Microbiome in Human Obesity: A Comprehensive Review
Alejandro Borrego-Ruiz, Juan J. Borrego
Biomedicines.2025; 13(9): 2173. CrossRef
Exploring the Anti-obesity Effects of Specific Medicinal Herbs: Focus on Herbal Approaches and their Role in Gut Microbiota
Sakshi Sharma, Avijit Mazumder
Current Pharmaceutical Biotechnology.2025; 26(12): 1882. CrossRef
Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review
Marcio J Concepción-Zavaleta, Jenyfer M Fuentes-Mendoza, Jhean G Gonzáles-Yovera, Gemma Y Ruvalcaba-Barbosa, Leonardo D Cura-Rodríguez, Josué S González-Rodríguez, Luis A Concepción-Urteaga, Aranza I Pérez-Reyes, Juan Eduardo Quiroz-Aldave, José Paz-Ibarr
World Journal of Gastroenterology.2025;[Epub] CrossRef
Paliurus ramosissimus Leaf Extract Inhibits Adipocyte Differentiation In Vitro and In Vivo High-Fat Diet-Induced Obesity Through PPARγ Suppression
Shin-Hye Kim, Tae Hyun Son, Hye-Lim Shin, Dongsoo Kim, Gwang Hun Park, Jeong Won Seo, Hwan-Gyu Kim, Sik-Won Choi
Pharmaceuticals.2025; 18(10): 1515. CrossRef
Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production
Xiaomin Feng, Hanlu Li, Jianxia Tian, Xuemei Han, Wu Liang, Feiliang Zhong, Xuegang Luo
Nutrients.2025; 17(22): 3525. CrossRef
Problems associated with the ATC system of drug classification
Lilly Josephine Bindel, Roland Seifert
Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
Apple polyphenol product, phlorizin or procyanidin B 2, alleviates transplanted obese patient fecal microbiota-induced obesity in mice by modulating the gut microbiota and related phages
Wenhui Li, Zunyang Song, Xin Xia, Xiaoyu Jiang, Dongxiao Sun-Waterhouse, Dapeng Li
Food Science and Human Wellness.2025; 14(11): 9250266. CrossRef
Shedding light on weight loss: A narrative review of medications for treating obesity
Haritha Darapaneni, Samridhi Lakhanpal, Hiren Chhayani, Kinna Parikh, Meet Patel, Vasu Gupta, Fnu Anamika, Ripudaman Munjal, Rohit Jain
Romanian Journal of Internal Medicine.2024; 62(1): 3. CrossRef
Projected health and economic effects of the increase in childhood obesity during the COVID-19 pandemic in England: The potential cost of inaction
Iván Ochoa-Moreno, Ravita Taheem, Kathryn Woods-Townsend, Debbie Chase, Keith M. Godfrey, Neena Modi, Mark Hanson, Rebecca F. Baggaley
PLOS ONE.2024; 19(1): e0296013. CrossRef
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki
Frontiers in Medicine.2024;[Epub] CrossRef
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
Manmeet Kaur, Saurav Misra
European Journal of Clinical Pharmacology.2024; 80(5): 669. CrossRef
Gut microbiota and therapy for obesity and type 2 diabetes
Luyao Zhang, Pai Wang, Juan Huang, Yanpeng Xing, F. Susan Wong, Jian Suo, Li Wen
Frontiers in Endocrinology.2024;[Epub] CrossRef
Adipocyte-targeted delivery of rosiglitazone with localized photothermal therapy for the treatment of diet-induced obesity in mice
Yunxiao Zhang, Maoqi Luo, Yaxin Jia, Tingting Gao, Li Deng, Tao Gong, Zhirong Zhang, Xi Cao, Yao Fu
Acta Biomaterialia.2024; 181: 317. CrossRef
Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis
Leonardo Zumerkorn Pipek, Walter Augusto Fabio Moraes, Rodrigo Massato Nobetani, Vitor Santos Cortez, Alberto Santos Condi, João Victor Taba, Rafaela Farias Vidigal Nascimento, Milena Oliveira Suzuki, Fernanda Sayuri do Nascimento, Vitoria Carneiro de Mat
Scientific Reports.2024;[Epub] CrossRef
Free radical scavenging, α-amylase, α-glucosidase, and lipase inhibitory activities of metabolites from strawberry kombucha: Molecular docking and in vitro studies
Adriyan Pramono, William Ben Gunawan, Fahrul Nurkolis, Darmawan Alisaputra, Gilbert Ansell Limen, Muhammad Subhan Alfaqih, Martha Ardiaria
Pharmacia.2024; 71: 1. CrossRef
“Dare to feel full”—A group treatment method for sustainable weight reduction in overweight and obese adults: A randomized controlled trial with 5-years follow-up
Sara Holmberg, Lena Lendahls, Kjell-Åke Alle, Aleksandra Klisic
PLOS ONE.2024; 19(5): e0303021. CrossRef
ANÁLISE DA PERDA DE PESO EM PACIENTES SUBMETIDOS A CIRURGIA BARIÁTRICA: REVISÃO SISTEMÁTICA DE LITERATURA
Lucas Bottesini dos Santos, Eduardo Barbosa Lopes, Cristianne Confessor Castilho Lopes, Suellen Balbinoti Fuzinatto, Maykon Ribeiro, Guilherme Lange, Viviane Dorgievicz, Éder Ricardo Haag, Yan Fincatto, Vanessa Macrhy
Revista Contemporânea.2024; 4(5): e4260. CrossRef
Kaempferia parviflora extract and its component polymethoxyflavones suppress adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via the AMPK pathway
Masakazu Ishii, Haruka Miyata, Nao Ikeda, Tomoaki Sakurai, Yurika Oura, Masahiro Nishimura
Molecular Biology Reports.2024;[Epub] CrossRef
What is known about the use of weight loss medication in women with overweight/obesity on fertility and reproductive health outcomes? A scoping review
Kate Maslin, Rabab Alkutbe, Jeremy Gilbert, Jonathan Pinkney, Jill Shawe
Clinical Obesity.2024;[Epub] CrossRef
Effect of Lythrum salicaria Extract on Body Fat Reduction: A Protocol for a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Hye-Jin Park, In Heo, Yea-Jin Park, Hyo-Jin An, Su Shin, Yun-Yeop Cha
Journal of Korean Medicine for Obesity Research.2024; 24(1): 87. CrossRef
Obesity and Weight Loss Strategies for Patients With Heart Failure
Amanda R. Vest, Philip R. Schauer, Jo E. Rodgers, Emily Sanderson, Courtney L. LaChute, Jessica Seltz, Carl J. Lavie, Stacy A. Mandras, W.H. Wilson Tang, Adrian daSilva-deAbreu
JACC: Heart Failure.2024; 12(9): 1509. CrossRef
The Effects of Propolis Consumption on Body Composition and Blood Pressure: A Systematic Review and Dose-Response Meta-Analysis
Mahdi Vajdi, Atefeh Bonyadian, Fatemeh Pourteymour Fard Tabrizi, Reza Hassanizadeh, Nooshin Noshadi, Beitullah Alipour, Mahdieh Abbasalizad-Farhangi, Melika Darzi, Sahar Golpour-Hamedani, Gholamreza Askari
Current Therapeutic Research.2024; 101: 100754. CrossRef
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Luigi Piero Greco, Luisa Gallo, Gaetano La Greca, Saverio Latteri
Heliyon.2024; 10(16): e35498. CrossRef
Association between glucagon‐like peptide‐1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database
Tae Hyeon Kim, Kyeongmin Lee, Seoyoung Park, Hanseul Cho, Jaeyu Park, Hyesu Jo, Yejun Son, Soeun Kim, Jiseung Kang, Lee Smith, Masoud Rahmati, Guillaume Fond, Laurent Boyer, Damiano Pizzol, Hayeon Lee, Sang Youl Rhee, Jiyoung Hwang, Hyunji Sang, Dong Keon
Diabetes, Obesity and Metabolism.2024; 26(11): 5183. CrossRef
Adipocyte-Targeted Nanocomplex with Synergistic Photothermal and Pharmacological Effects for Combating Obesity and Related Metabolic Syndromes
Yuanyuan Zhang, Xiaojiao Zeng, Fan Wu, Xiaopeng Yang, Tingting Che, Yin Zheng, Jie Li, Yufei Zhang, Xinge Zhang, Zhongming Wu
Nanomaterials.2024; 14(16): 1363. CrossRef
Advancements in Understanding and Preventing Obesity-Related Colon Cancer
Christine Shieh, Henry J. Thompson, Eric McLaughlin, Chien-Wei Chiang, Hisham Hussan
The Cancer Journal.2024; 30(5): 357. CrossRef
Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes
Federico Losada-Díaz, Santiago Lizarazo-Bocanegra, Juan J. Perdomo-Lugo, Sebastián A. Gutiérrez-Romero, Isabella Correa-Osio, Carlos O. Mendivil
Diabetes Therapy.2024; 15(11): 2279. CrossRef
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
João Carlos Locatelli, Juliene Gonçalves Costa, Andrew Haynes, Louise H. Naylor, P. Gerry Fegan, Bu B. Yeap, Daniel J. Green
Diabetes Care.2024; 47(10): 1718. CrossRef
Lactobacillus acidophilus CICC 6075 attenuates high-fat diet-induced obesity by improving gut microbiota composition and histidine biosynthesis
Shenyang ZHANG, Shuai YANG, Yun ZHUANG, Dan YANG, Xiqun GU, Yi WANG, Zhenzhen WANG, Renjin CHEN, Fuling YAN
Bioscience of Microbiota, Food and Health.2024; 43(4): 367. CrossRef
Medicinal Plants and Natural Products to Treat Obesity through Inhibiting Pancreatic Lipase: A Review (2020-2022)
Khaoula Jamai, Nour Elhouda Daoudi, Amal Elrherabi, Mohamed Bnouham
Letters in Drug Design & Discovery.2024; 21(11): 1936. CrossRef
Withanolides-enriched leaf extract of Withania somnifera exert anti-obesity effects by inducing brown adipocyte-like phenotype via tuning MAP-kinase signaling axis
Acharya Balkrishna, Priya Kumari, Pratibha Singh, Nishit Pathak, Sudeep Verma, Rishabh Dev, Anurag Varshney
International Journal of Biological Macromolecules.2024; 282: 136883. CrossRef
Morus alba: natural and valuable effects in weight loss management
Foteini Ntalouka, Athina Tsirivakou
Frontiers in Clinical Diabetes and Healthcare.2024;[Epub] CrossRef
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity
Urja Amin, Dora Huang, Arun Dhir, Anya E Shindler, Ashley E Franks, Colleen J Thomas
Gut Microbes.2024;[Epub] CrossRef
Como tratar a obesidade associada à diabetes tipo 2?
Carina Proença, Ana T. Rufino, Marisa Freitas, Eduarda Fernandes
Revista de Ciência Elementar.2024;[Epub] CrossRef
Exploration of the Mechanism of Guaijaverin in Inhibiting Pancreatic Lipase Based on Multispectral Method, Molecular Docking, and Oral Lipid Tolerance Test in Rats
Xinyu Gao, Kaijie Jia, Hong Li, Shujun Liu, Yang Wang, Jinlong Tian, Xin Zhao, Pan Zhao
Luminescence.2024;[Epub] CrossRef
Review on obesity management: diet, exercise and pharmacotherapy
Katya Peri, Mark Eisenberg
BMJ Public Health.2024; 2(2): e000246. CrossRef
NEWLY-EMERGING SIDE EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE USAGE ASSOCIATED WITH WEIGHT LOSS TREATMENT
Paula Bieganek, Bartosz Sadłowski, Stanisław Łukaszewicz, Piotr Pawłowski, Julia Rybak, Jakub Kordialik, Julia Koćwin, Sandra Sarnacka, Michał Tokarski, Angelika Banasiak
Health Problems of Civilization.2024;[Epub] CrossRef
Efficacy of endoscopic resuturing versus pharmacotherapy to treat weight recidivism after endoscopic sleeve gastroplasty
Kaveh Hajifathalian, Okeefe Simmons, Mohamed Abu-Hammour, Kamal Hassan, Reem Z. Sharaiha
Gastrointestinal Endoscopy.2023; 98(6): 944. CrossRef
Gardenia fruit and Eucommia leaves combination improves hyperlipidemia and hyperglycemia via pancreatic lipase and AMPK-PPARα and Keap-1-Nrf2-HO-1 regulation
Xiaotong Su, Shun Hao, Wenna Li, Xu Li, Zhentao Mo, Yiqi Li, Lu Xiao, Wenjun Wang, Feng Wang
Journal of Functional Foods.2023; 100: 105394. CrossRef
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
Yan Li, Wenjuan Yang, Yuanyuan Zheng, Weiqi Dai, Jie Ji, Liwei Wu, Ziqi Cheng, Jie Zhang, Jingjing Li, Xuanfu Xu, Jianye Wu, Mingwei Yang, Jiao Feng, Chuanyong Guo
Journal of Experimental & Clinical Cancer Research.2023;[Epub] CrossRef
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Gideon G. Kang, Natalie L. Trevaskis, Andrew J. Murphy, Mark A. Febbraio
iScience.2023; 26(1): 105905. CrossRef
The gut microbiota in obesity and weight management: microbes as friends or foe?
Matthias Van Hul, Patrice D. Cani
Nature Reviews Endocrinology.2023; 19(5): 258. CrossRef
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906
Arvid Jungnik, Jorge Arrubla Martinez, Leona Plum‐Mörschel, Christoph Kapitza, Daniela Lamers, Claus Thamer, Corinna Schölch, Michael Desch, Anita M. Hennige
Diabetes, Obesity and Metabolism.2023; 25(4): 1011. CrossRef
From Metabolic Syndrome to Type 2 Diabetes in Youth
Dario Iafusco, Roberto Franceschi, Alice Maguolo, Salvatore Guercio Nuzio, Antonino Crinò, Maurizio Delvecchio, Lorenzo Iughetti, Claudio Maffeis, Valeria Calcaterra, Melania Manco
Children.2023; 10(3): 516. CrossRef
Excess body weight: Novel insights into its roles in obesity comorbidities
Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, Jun Yu
Seminars in Cancer Biology.2023; 92: 16. CrossRef
Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis
Gabriela Ribeiro, Ana Maia, Gonçalo Cotovio, Francisco P. M. Oliveira, Durval C. Costa, Albino J. Oliveira-Maia
Scientific Reports.2023;[Epub] CrossRef
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
Ainhoa Gómez Lumbreras, Malinda S. Tan, Lorenzo Villa-Zapata, Sabrina Ilham, Jacob C. Earl, Daniel C. Malone
Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(6): 1268. CrossRef
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer
Simon P. de Leeuw, Melinda A. Pruis, Barend J. Sikkema, Mostafa Mohseni, G. D. Marijn Veerman, Marthe S. Paats, Daphne W. Dumoulin, Egbert F. Smit, Annemie M.W. J. Schols, Ron H.J. Mathijssen, Elisabeth F.C. van Rossum, Anne-Marie C. Dingemans
Journal of Thoracic Oncology.2023; 18(8): 1017. CrossRef
Role of flavonoids in controlling obesity: molecular targets and mechanisms
Anns Mahboob, Samson Mathews Samuel, Arif Mohamed, Mohmmad Younus Wani, Sofiane Ghorbel, Nabil Miled, Dietrich Büsselberg, Ali Chaari
Frontiers in Nutrition.2023;[Epub] CrossRef
The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD
Eui Jung Jung, Ki Woon Sung, Tae Hyun Bae, Hee-Yeon Kim, Ha Rim Choi, Sung Hyun Kim, Chan Hoon Jung, Su Ran Mun, Yeon Sung Son, Shin Kim, Young Ho Suh, Anna Kashina, Joo-Won Park, Yong Tae Kwon
Metabolism.2023; 146: 155644. CrossRef
Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation
Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi, Alan D. Kaye
Health Psychology Research.2023; 11(1): 1. CrossRef
Recent advancements in pharmacological strategies to modulate energy balance for combating obesity
Benudhara Pati, Satyabrata Sendh, Bijayashree Sahu, Sunil Pani, Nivedita Jena, Naresh Chandra Bal
RSC Medicinal Chemistry.2023; 14(8): 1429. CrossRef
Management of abdominal wall hernias in patients with severe obesity
Omar M. Ghanem, Sean Orenstein, S. Julie-Ann Lloyd, Amin Andalib, Alice Race, Holly Ann Burt, Farah Husain, Matthew Goldblatt, Matthew Kroh
Surgical Endoscopy.2023; 37(9): 6619. CrossRef
Obesity-related hypertension and chronic kidney disease: from evaluation to management
Mi-Hyang Jung, Sang-Hyun Ihm
Kidney Research and Clinical Practice.2023; 42(4): 431. CrossRef
Antiepileptics pharmacotherapy or antidiabetics may hold potential in ‎treatment of ‎‎epileptic ‎patients with diabetes mellitus: A narrative review
Marwan AL-NİMER, Saeed AL-ZUHAİRY
Hacettepe University Journal of the Faculty of Pharmacy.2023;[Epub] CrossRef
Medicamentos antidiabéticos utilizados com a finalidade de perda de peso
Sâmia Moreira de ANDRADE, Maria Victória Macedo de ANDRADE, Pedro Henrique Almeida de FARIA, Luís Marcelo Vieira ROSA, Plínio Robson Cavalcante COSTA, Luiz Gustavo Freitas PIRES
Diversitas Journal.2023;[Epub] CrossRef
Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon
Christian L. Roth, Anna Zenno
Frontiers in Endocrinology.2023;[Epub] CrossRef
Obesity: What’s Old, What’s New and How We Manage It: An Integrated Approach in Pharmacy Practice
Ângelo Jesus
FarmaJournal.2023; 8(2): 45. CrossRef
Integrating Pharmacotherapy and Psychotherapy for Weight Loss
Marla Sanzone, Morgan Sammons
Journal of Health Service Psychology.2023; 49(4): 177. CrossRef
The Therapeutic Aspects of Obesity
Tetiana Bentsa
Family medicine. European practices.2023; (3): 88. CrossRef
Effect of Lingguizhugan decoction in activating fat mobilization in obesity
Yubin YANG, Yunlong WANG, Zhengbang SUN, Ting DU, Ying YANG, Jiaojiao CHEN, Meiling WANG, Hairong LI, Jian QIN
Journal of Holistic Integrative Pharmacy.2022; 3(1): 68. CrossRef
Computational approaches to predicting treatment response to obesity using neuroimaging
Leonard Kozarzewski, Lukas Maurer, Anja Mähler, Joachim Spranger, Martin Weygandt
Reviews in Endocrine and Metabolic Disorders.2022; 23(4): 773. CrossRef
Delivery of miRNAs to the adipose organ for metabolic health
Karin Kornmueller, Ez-Zoubir Amri, Marcel Scheideler, Ruth Prassl
Advanced Drug Delivery Reviews.2022; 181: 114110. CrossRef
Purple sweet potato leaf extracts suppress adipogenic differentiation of human bone marrow–derived mesenchymal stem cells
Masakazu Ishii, Nao Ikeda, Haruka Miyata, Manami Takahashi, Masahiro Nishimura
Journal of Food Biochemistry.2022;[Epub] CrossRef
The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models
Jianbo Wu, Kenchi Miyasaka, Wakana Yamada, Shogo Takeda, Norihito Shimizu, Hiroshi Shimoda
Molecules.2022; 27(3): 607. CrossRef
Pharmacotherapeutic options in pediatric obesity: an urgent call for further research
María Florencia González Bagnes, Claudio González, Valeria Hirschler, Guillermo Di Girolamo
Expert Opinion on Pharmacotherapy.2022; 23(8): 869. CrossRef
Russelioside B: a Pregnane Glycoside with Pharmacological Potential
Essam Abdel-Sattar, Dalia E. Ali
Revista Brasileira de Farmacognosia.2022; 32(2): 188. CrossRef
Pharmacotherapy in Childhood Obesity
Peter Kühnen, Heike Biebermann, Susanna Wiegand
Hormone Research in Paediatrics.2022; 95(2): 177. CrossRef
Effects of Vinegar/Acetic Acid Intake on Appetite Measures and Energy Consumption: Systematic Review
Faten O. Hasan, Kristen P. Hamilton, Siddhartha S. Angadi, Sibylle Kranz
Translational Journal of the American College of Sports Medicine.2022;[Epub] CrossRef
Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management
Fajuan Rui, Hongli Yang, Xinyu Hu, Qi Xue, Yayun Xu, Junping Shi, Jie Li
Infectious Microbes and Diseases.2022; 4(2): 49. CrossRef
Treatments for obesity in the context of nonalcoholic steatohepatitis and mental health
Aadi Sharma, Somaya Albhaisi, Arun J. Sanyal
Clinical Liver Disease.2022; 20(2): 48. CrossRef
A narrative review of anti-obesity medications for obese patients with osteoarthritis
Win Min Oo, Ali Mobasheri, David J Hunter
Expert Opinion on Pharmacotherapy.2022; 23(12): 1381. CrossRef
Sulfated Glucan from the Green Seaweed Caulerpa sertularioides Inhibits Adipogenesis through Suppression of Adipogenic and Lipogenic Key Factors
Gildacio Chaves Filho, Lucas Batista, Silvia de Medeiros, Hugo Rocha, Susana Moreira
Marine Drugs.2022; 20(8): 470. CrossRef
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Nasser M Alorfi, Alanood S Algarni
Clinical Pharmacology: Advances and Applications.2022; Volume 14: 61. CrossRef
The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms
Lingyue Shan, Akanksha Tyagi, Umair Shabbir, Xiuqin Chen, Selvakumar Vijayalakshmi, Pianpian Yan, Deog-Hwan Oh
Fermentation.2022; 8(8): 376. CrossRef
Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota
Jin Jin, Jiani Wang, Ruyue Cheng, Yan Ren, Zhonghua Miao, Yating Luo, Qingqing Zhou, Yigui Xue, Xi Shen, Fang He, Haoming Tian
Frontiers in Microbiology.2022;[Epub] CrossRef
N-linoleyltyrosine ameliorates high-fat diet-induced obesity in C57BL/6 mice via cannabinoid receptor regulation
Zheng-yu Yang, Yi-ying Wu, Yi Zhou, Yun-qi Yang, Jia-hui Zhang, Tao He, Sha Liu
Frontiers in Endocrinology.2022;[Epub] CrossRef
Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults
Megan O. Bensignor, Aaron S. Kelly, Silva Arslanian
Frontiers in Endocrinology.2022;[Epub] CrossRef
Blockade of CXXC5-dishevelled interaction inhibits adipogenic differentiation, obesity, and insulin resistance in mice
Seol Hwa Seo, Dasung Lee, Soung-Hoon Lee, Kang-Yell Choi
Scientific Reports.2022;[Epub] CrossRef
Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
Itzel G. Salazar-Valencia, Hugo Villamil-Ramírez, Francisco Barajas-Olmos, Martha Guevara-Cruz, Luis R. Macias-Kauffer, Humberto García-Ortiz, Omar Hernández-Vergara, David Alberto Díaz de Sandy-Galán, Paola León-Mimila, Federico Centeno-Cruz, Luis E. Gon
Genes.2022; 13(12): 2267. CrossRef
A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management
Clara García-Carro, Ander Vergara, Sheila Bermejo, María A. Azancot, Joana Sellarés, Maria José Soler
Frontiers in Medicine.2021;[Epub] CrossRef
Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery
Marvin Wei Jie Chua, Boon Cheok Lai
Obesity Surgery.2021; 31(8): 3874. CrossRef
BMI Course Over 10 Years After Bariatric Surgery and Biopsychosocial Complexity Assessed with the INTERMED: a Retrospective Study
Yann Corminboeuf, Beate Wild, Catherine Zdrojewski, Dieter Schellberg, Lucie Favre, Michel Suter, Friedrich Stiefel
Obesity Surgery.2021; 31(9): 3996. CrossRef
The Role of Positron Emission Tomography in Bariatric Surgery Research: a Review
Jason Bini, Mathieu Norcross, Maija Cheung, Andrew Duffy
Obesity Surgery.2021; 31(10): 4592. CrossRef
Anti-Obesity Effect of Hot Water Extract of Barley Sprout through the Inhibition of Adipocyte Differentiation and Growth
Myeong-Jin Kim, Hye-Won Kawk, Sang-Hyeon Kim, Hyo-Jae Lee, Ji-Won Seo, Jong-Tae Kim, Seung-Hee Jang, Min-Jeong Kim, Young-Min Kim
Metabolites.2021; 11(9): 610. CrossRef
Anti-Obesity Effect of Polygalin C Isolated from Polygala japonica Houtt. via Suppression of the Adipogenic and Lipogenic Factors in 3T3-L1 Adipocytes
Wona Jee, Seung-Hyeon Lee, Hyun Min Ko, Ji Hoon Jung, Won-Seok Chung, Hyeung-Jin Jang
International Journal of Molecular Sciences.2021; 22(19): 10405. CrossRef
The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
Nabil Rabhi, Kathleen Desevin, Briana Noel Cortez, Ryan Hekman, Jean Z. Lin, Andrew Emili, Stephen R. Farmer
Scientific Reports.2021;[Epub] CrossRef
Chlorogenic Acids Inhibit Adipogenesis: Implications of Wnt/β-Catenin Signaling Pathway
Mengting Liu, Jian Qin, Jing Cong, Yubin Yang, Muhittin Yurekli
International Journal of Endocrinology.2021; 2021: 1. CrossRef
Médicaments anti-obésité : leçons des échecs pour l’avenir
André J. Scheen
Médecine des Maladies Métaboliques.2021; 15(8): 734. CrossRef
Obesity and Eating Disorders in Children and Adolescents: The Bidirectional Link
Stella Stabouli, Serap Erdine, Lagle Suurorg, Augustina Jankauskienė, Empar Lurbe
Nutrients.2021; 13(12): 4321. CrossRef
MEK6 Overexpression Exacerbates Fat Accumulation and Inflammatory Cytokines in High-Fat Diet-Induced Obesity
Suyeon Lee, Myoungsook Lee
International Journal of Molecular Sciences.2021; 22(24): 13559. CrossRef
Skin and obesity in childhood: an update
Valeria Hirschler
AIMS Medical Science.2021; 8(4): 311. CrossRef
An Avocado Extract Enriched in Mannoheptulose Prevents the Negative Effects of a High-Fat Diet in Mice
Paul J. Pistell, Tadanobu Utsuki, Joseph Francis, Philip J. Ebenezer, Jennifer Terrebonne, George S. Roth, Donald K. Ingram
Nutrients.2021; 14(1): 155. CrossRef

Original Articles

Obesity and Metabolic Syndrome
Air Pollution Has a Significant Negative Impact on Intentional Efforts to Lose Weight: A Global Scale Analysis: Morena Ustulin, So Young Park, Sang Ouk Chin, Suk Chon, Jeong-taek Woo, Sang Youl Rhee; Diabetes Metab J. 2018;42(4):320-329. Published online April 24, 2018; DOI: https://doi.org/10.4093/dmj.2017.0104

8,335 View
52 Download
7 Web of Science
9 Crossref

Abstract PDF PubReader ePub

Background

Air pollution causes many diseases and deaths. It is important to see how air pollution affects obesity, which is common worldwide. Therefore, we analyzed data from a smartphone application for intentional weight loss, and then we validated them.

Methods

Our analysis was structured in two parts. We analyzed data from a cohort registered to a smartphone application in 10 large cities of the world and matched it with the annual pollution values. We validated these results using daily pollution data in United States and matching them with user information. Body mass index (BMI) variation between final and initial login time was considered as outcome in the first part, and daily BMI in the validation. We analyzed: daily calories intake, daily weight, daily physical activity, geographical coordinates, seasons, age, gender. Weather Underground application programming interface provided daily climatic values. Annual and daily values of particulate matter PM10 and PM2.5 were extracted. In the first part of the analysis, we used 2,608 users and then 995 users located in United States.

Results

Air pollution was highest in Seoul and lowest in Detroit. Users decreased BMI by 2.14 kg/m² in average (95% confidence interval, −2.26 to −2.04). From a multilevel model, PM10 (β=0.04, P=0.002) and PM2.5 (β=0.08, P<0.001) had a significant negative effect on weight loss when collected per year. The results were confirmed with the validation (β_AQI*time=1.5×10^–5; P<0.001) by mixed effects model.

Conclusion

This is the first study that shows how air pollution affects intentional weight loss applied on wider area of the world.

Citations

Citations to this article as recorded by

A systematic review of evidence that environmental contaminant exposure impedes weight loss and glycemic control during calorie‐restricted diets in humans
Kimberley Ann Bennett, Calum Sutherland, Anne Louise Savage
Obesity Reviews.2025;[Epub] CrossRef
What could be the reasons for not losing weight even after following a weight loss program?
Jyoti Dabas, S. Shunmukha Priya, Akshay Alawani, Praveen Budhrani
Journal of Health, Population and Nutrition.2024;[Epub] CrossRef
Subchronic exposure to 1,2-naphthoquinone induces adipose tissue inflammation and changes the energy homeostasis of mice, partially due to TNFR1 and TLR4
Clílton Kraüss de Oliveira Ferreira, Clara Machado Campolim, Olívia Pizetta Zordão, Fernando Moreira Simabuco, Chadi Pellegrini Anaruma, Rodrigo Martins Pereira, Vitor Ferreira Boico, Luiz Guilherme Salvino, Maíra Maftoum Costa, Nathalia Quintero Ruiz, Le
Toxicology Reports.2023; 11: 10. CrossRef
Effects of Ambient Particulate Matter (PM2.5) Exposure on Calorie Intake and Appetite of Outdoor Workers
Thavin Kumar Mathana Sundram, Eugenie Sin Sing Tan, Hwee San Lim, Farahnaz Amini, Normina Ahmad Bustami, Pui Yee Tan, Navedur Rehman, Yu Bin Ho, Chung Keat Tan
Nutrients.2022; 14(22): 4858. CrossRef
Efficiency in reducing air pollutants and healthcare expenditure in the Seoul Metropolitan City of South Korea
Subal C. Kumbhakar, Jiyeon An, Masoomeh Rashidghalam, Almas Heshmati
Environmental Science and Pollution Research.2021; 28(20): 25442. CrossRef
Seasonal variation and trends in the Internet searches for losing weight: An infodemiological study
Ying Teng, Shun-Wei Huang, Zhen Li, Qiao-Mei Xie, Man Zhang, Qiu-Yue Lou, Fang Wang, Yan-Feng Zou
Obesity Research & Clinical Practice.2020; 14(3): 225. CrossRef
Estimation of health benefits from air quality improvement using the MODIS AOD dataset in Seoul, Korea
Daeun Kim, Jeongyeong Kim, Jaehwan Jeong, Minha Choi
Environmental Research.2019; 173: 452. CrossRef
Appropriate Medical Technology in the Era of the 4th Industrial Revolution
Sang Youl Rhee
The Korean Journal of Medicine.2019; 94(5): 387. CrossRef
Can Air Pollution Biologically Hinder Efforts to Lose Body Weight?
Duk-Hee Lee
Diabetes & Metabolism Journal.2018; 42(4): 282. CrossRef

Obesity and Metabolic Syndrome
Importance of Lean Muscle Maintenance to Improve Insulin Resistance by Body Weight Reduction in Female Patients with Obesity: Yaeko Fukushima, Satoshi Kurose, Hiromi Shinno, Ha Cao Thu, Nana Takao, Hiromi Tsutsumi, Yutaka Kimura; Diabetes Metab J. 2016;40(2):147-153. Published online March 27, 2016; DOI: https://doi.org/10.4093/dmj.2016.40.2.147

8,029 View
58 Download
33 Web of Science
33 Crossref

Abstract PDF PubReader ePub

Background

It has recently been suggested that skeletal muscle has an important role in insulin resistance in obesity, in addition to exercise tolerance and the fat index. The aim of this study was to identify body composition factors that contribute to improvement of insulin resistance in female patients with obesity who reduce body weight.

Methods

We studied 92 female obese patients (age 40.9±10.4 years, body mass index 33.2±4.6 kg/m²) who reduced body weight by ≥5% after an intervention program including diet, exercise therapy, and cognitive behavioral therapy. Before and after the intervention, body composition was evaluated by dual-energy X-ray absorptiometry to examine changes in skeletal muscle mass. Homeostasis model assessment of insulin resistance (HOMA-IR) was measured as an index of insulin resistance. Cardiopulmonary exercise was also performed by all patients.

Results

There were significant improvements in body weight (–10.3%±4.5%), exercise tolerance (anaerobic threshold oxygen uptake 9.1%±18.4%, peak oxygen uptake 11.0%±14.2%), and HOMA-IR (–20.2%±38.3%). Regarding body composition, there were significant decreases in total body fat (–19.3%±9.6%), total fat-free mass (–2.7%±4.3%), and % body fat (–10.1%±7.5%), whereas % skeletal muscle significantly increased (8.9%±7.2%). In stepwise multiple linear regression analysis with change in HOMA-IR as the dependent variable, the change in % skeletal muscle was identified as an independent predictor (β=–0.280, R²=0.068, P<0.01).

Conclusion

Improvement of insulin resistance in female obese patients requires maintenance of skeletal muscle mass.

Citations

Citations to this article as recorded by

Liver lipid metabolism, oxidative stress, and inflammation in glutamine-supplemented ob/ob mice
Jaqueline Santos Moreira Leite, Eloisa Aparecida Vilas-Boas, Hilton K. Takahashi, Ana Cláudia Munhoz, Layanne C.C. Araújo, Carla Roberta Carvalho, Jose Donato Jr, Rui Curi, Angelo Rafael Carpinelli, Vinicius Cruzat
The Journal of Nutritional Biochemistry.2025; 138: 109842. CrossRef
Consequences of Dietary Manganese-Based Nanoparticles Supplementation or Deficiency on Systemic Health and Gut Metabolic Dynamics in Rats
Przemysław Sołek, Karolina Różaniecka, Jerzy Juśkiewicz, Bartosz Fotschki, Anna Stępniowska, Katarzyna Ognik
Nanotechnology, Science and Applications.2025; Volume 18: 19. CrossRef
Decreased muscle percentage and increased fat percentage associated with obstructive sleep apnea syndrome severity in males: Insight from body composition and polysomnogram
Yinghui Gao, Libo Zhao, Li Fan, Weimeng Cai, Dong Rui, Zhe Zhao, Tingyu Nie, Tianjiao Li, Xin Xue, Cong Ma, Hongju Xiao, Lin Liu
Heliyon.2025; 11(6): e43131. CrossRef
Effects of a multicomponent intervention on body composition and cardiovascular risk factors in women with obesity– a randomized clinical trial
Leyla Esmealy, Babak Esmealy, Farhad Vahid, Javad Vakili
Journal of Diabetes & Metabolic Disorders.2025;[Epub] CrossRef
Sarcopenia prevalence between obese and morbid obese patients in an obesity center
Mujgan Tuna, Arzu Cennet Işık , Ozlem Hürmeydan
Journal of Surgery and Medicine.2024; 8(4): 73. CrossRef
Association between insulin sensitivity and lean mass loss during weight loss
Ciera L. Bartholomew, Catia Martins, Barbara Gower
Obesity.2024; 32(6): 1156. CrossRef
Dietary behaviour change intervention for managing sarcopenic obesity among community-dwelling older people: a pilot randomised controlled trial
Yue-Heng Yin, Justina Yat Wa Liu, Maritta Välimäki
BMC Geriatrics.2023;[Epub] CrossRef
Diet and Exercise in the Management of Polycystic Ovary Syndrome: Practical Considerations for Person-Centered Care
Giorgia E. Colombo, Stephanie Pirotta, Angelo Sabag
Seminars in Reproductive Medicine.2023; 41(01/02): 026. CrossRef
Effect of Mobility Restrictions During the Coronavirus Disease Epidemic on Body Composition and Exercise Tolerance in Patients With Obesity: Single Institutional Retrospective Cohort Study
Yoshinari Matsumoto, Satoshi Kurose, Takumi Miyauchi, Sawako Yoshiuchi, Daiki Habu, Yutaka Kimura
Journal of Physical Activity and Health.2022; 19(5): 351. CrossRef
Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus
Che-Sheng Pai, Cheng-Yuan Wang, Wei-Wen Hung, Wei-Chun Hung, Hui-Ju Tsai, Chen-Chia Chang, Shang-Jyh Hwang, Chia-Yen Dai, Wen-Yu Ho, Yi-Chun Tsai
Journal of Personalized Medicine.2022; 12(4): 617. CrossRef
Exercise and Nutrition Strategies for Combating Sarcopenia and Type 2 Diabetes Mellitus in Older Adults
Dionysia Argyropoulou, Nikolaos D. Geladas, Tzortzis Nomikos, Vassilis Paschalis
Journal of Functional Morphology and Kinesiology.2022; 7(2): 48. CrossRef
Branched-Chain and Aromatic Amino Acids in Relation to Fat Mass and Fat-Free Mass Changes among Adolescents: A School-Based Intervention
Magnoudewa Priscille Pana, Pierre Ayotte, Elhadji Anassour-Laouan-Sidi, Edouard Suhas, Clémence Mahana Iti Gatti, Michel Lucas
Metabolites.2022; 12(7): 589. CrossRef
Exercising for Insulin Sensitivity – Is There a Mechanistic Relationship With Quantitative Changes in Skeletal Muscle Mass?
Jasmine Paquin, Jean-Christophe Lagacé, Martin Brochu, Isabelle J. Dionne
Frontiers in Physiology.2021;[Epub] CrossRef
The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program
Nana Takao, Satoshi Kurose, Takumi Miyauchi, Katsuko Onishi, Atsuko Tamanoi, Ryota Tsuyuguchi, Aya Fujii, Sawako Yoshiuchi, Kazuhisa Takahashi, Hiromi Tsutsumi, Yutaka Kimura
BMC Endocrine Disorders.2021;[Epub] CrossRef
Exercise induces favorable metabolic changes in white adipose tissue preventing high‐fat diet obesity
Babu R. Maharjan, Sergio F. Martinez‐Huenchullan, Susan V. Mclennan, Stephen M. Twigg, Paul F. Williams
Physiological Reports.2021;[Epub] CrossRef
THE RELATIONSHIP BETWEEN INSULIN RESISTANCE AND FA-TIGUE SYMPTOM IN FIBROMYALGIA SYNDROME
Türkan Turgay, Zekiye İpek Katirci Kirmaci, Pınar Günel Karadeniz, Mehmet Baştemir
International Journal of Research -GRANTHAALAYAH.2020; 8(3): 271. CrossRef
Epicardial adipose tissue is tightly associated with exercise intolerance in patients with type 2 diabetes mellitus with asymptomatic left ventricular structural and functional abnormalities
Yousuke Sugita, Katsuhiko Ito, Shigeki Sakurai, Satoshi Sakai, Shinya Kuno
Journal of Diabetes and its Complications.2020; 34(5): 107552. CrossRef
Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss
Anna Thorsø Larsen, Nina Sonne, Kim V. Andreassen, Morten A. Karsdal, Kim Henriksen
The Journal of Pharmacology and Experimental Therapeutics.2020; 373(2): 269. CrossRef
Healthy dietary pattern and their corresponding gut microbiota profile are linked to a lower risk of type 2 diabetes, independent of the presence of obesity
D.A. Díaz-Rizzolo, B. Kostov, M. López-Siles, A. Serra, C. Colungo, L. González-de-Paz, M. Martinez-Medina, A. Sisó-Almirall, R. Gomis
Clinical Nutrition.2020; 39(2): 524. CrossRef
Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program

Haruhiko Nishida, Katsuko Onishi, Satoshi Kurose, Hiromi Tsutsumi, Takumi Miyauchi, Nana Takao, Sawako Yoshiuchi, Aya Fujii, Yutaka Kimura
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 2157. CrossRef
Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study
Jee Hee Yoo, Gyuri Kim, Sung Woon Park, Min Sun Choi, Jiyeon Ahn, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Mira Kang, Jae Hyeon Kim
Scientific Reports.2020;[Epub] CrossRef
Effects of body weight loss program on parameters of muscle performance in female obese adults
Gian Pietro Emerenziani, Dafne Ferrari, Silvia Migliaccio, Andrea Lenzi, Emanuela A. Greco, Chiara Marocco, Carlo Baldari, Laura Guidetti
The Journal of Sports Medicine and Physical Fitness.2019;[Epub] CrossRef
Reduced Lean Body Mass and Cardiometabolic Diseases in Adult Males with Overweight and Obesity: A Pilot Study
Shirine Khazem, Leila Itani, Dima Kreidieh, Dana El Masri, Hana Tannir, Roberto Citarella, Marwan El Ghoch
International Journal of Environmental Research and Public Health.2018; 15(12): 2754. CrossRef
Physical performance measures in screening for reduced lean body mass in adult females with obesity
M. El Ghoch, A.P. Rossi, S. Calugi, S. Rubele, F. Soave, M. Zamboni, E. Chignola, G. Mazzali, P.V. Bazzani, R. Dalle Grave
Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(9): 917. CrossRef
Testosterone a key factor in gender related metabolic syndrome
V. E. Bianchi, V. Locatelli
Obesity Reviews.2018; 19(4): 557. CrossRef
Burly1 is a mouse QTL for lean body mass that maps to a 0.8-Mb region of chromosome 2
Cailu Lin, Brad D. Fesi, Michael Marquis, Natalia P. Bosak, Anna Lysenko, Mohammed Amin Koshnevisan, Fujiko F. Duke, Maria L. Theodorides, Theodore M. Nelson, Amanda H. McDaniel, Mauricio Avigdor, Charles J. Arayata, Lauren Shaw, Alexander A. Bachmanov, D
Mammalian Genome.2018; 29(5-6): 325. CrossRef
Hypoxic Training Improves Normoxic Glucose Tolerance in Adolescents with Obesity
ESTELLE DE GROOTE, FLORIAN A. BRITTO, LOÏC BULLOCK, MARIE FRANÇOIS, CARINE DE BUCK, HENRI NIELENS, LOUISE DELDICQUE
Medicine & Science in Sports & Exercise.2018; 50(11): 2200. CrossRef
Lipid modulation of skeletal muscle mass and function
Christopher Lipina, Harinder S Hundal
Journal of Cachexia, Sarcopenia and Muscle.2017; 8(2): 190. CrossRef
Angiotensin-Converting Enzyme Ins/Del Polymorphism and Body Composition: The Intermediary Role of Hydration Status
Laura Bordoni, Valerio Napolioni, Francesca Marchegiani, Emilio Amadio, Rosita Gabbianelli
Lifestyle Genomics.2017; 10(1-2): 1. CrossRef
Influence of segmental body composition and adiposity hormones on resting metabolic rate and substrate utilization in overweight and obese adults
K. R. Hirsch, A. E. Smith-Ryan, M. N. M. Blue, M. G. Mock, E. T. Trexler
Journal of Endocrinological Investigation.2017; 40(6): 635. CrossRef
Carbohydrate-Restriction with High-Intensity Interval Training: An Optimal Combination for Treating Metabolic Diseases?
Monique E. Francois, Jenna B. Gillen, Jonathan P. Little
Frontiers in Nutrition.2017;[Epub] CrossRef
Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes
Y-M Park, S E Steck, T T Fung, J Zhang, L J Hazlett, K Han, A T Merchant
International Journal of Obesity.2016; 40(10): 1541. CrossRef
Effects of Body Weight Reduction on Serum Irisin and Metabolic Parameters in Obese Subjects
Yaeko Fukushima, Satoshi Kurose, Hiromi Shinno, Ha Cao Thi Thu, Nana Takao, Hiromi Tsutsumi, Takaaki Hasegawa, Toshiaki Nakajima, Yutaka Kimura
Diabetes & Metabolism Journal.2016; 40(5): 386. CrossRef

The Small Rice Bowl-Based Meal Plan was Effective at Reducing Dietary Energy Intake, Body Weight, and Blood Glucose Levels in Korean Women with Type 2 Diabetes Mellitus: Hee Jung Ahn, Kyung Ah Han, Hwi Ryun Kwon, Kyung Wan Min; Korean Diabetes J. 2010;34(6):340-349. Published online December 31, 2010; DOI: https://doi.org/10.4093/kdj.2010.34.6.340

7,108 View
44 Download
6 Crossref

Abstract PDF PubReader ePub

Background

The typical Korean diet includes rice, which is usually served in a rice bowl. We investigated the effects of a meal plan using rice bowls of varying sizes on dietary energy intake (EI), body weight (BW), and blood glucose levels.

Methods

Forty-two obese women with type 2 diabetes mellitus were randomly assigned to use either a 200 mL small rice bowl (SB), a 380 mL regular rice bowl (RB), or to a control group (C). Both intervention groups were asked to reduce their EI by 500 kcal/day for 12 weeks and simple instructions for using the assigned bowl were provided. Dietary EI and proportion of macronutrients (PMN) were estimated from 3-day dietary records.

Results

Reduction of EI was more prominent in the SB group compared to the RB and C group, although EI decreased significantly from baseline in all groups. Carbohydrate and fat intakes of the SB group were decreased greater than those of the RB and C group. However, changes in PMN were not significant across the 3 groups. Reduction of BW and HbA1c levels in the SB group was more prominent compared to the C group. Although, BW and HbA1c were decreased significantly from baseline in both bowl groups. There was no statistical difference between the two groups.

Conclusion

The small rice bowl-based meal plan was effective at reducing EI, BW, and blood glucose levels, and the observed reductions in EI, carbohydrate, and fat intake were greater than those of the regular rice bowl-based meal plan.

Citations

Citations to this article as recorded by

Enhanced glycemic control and cardiovascular risk reduction in type 2 diabetes patients using quantified tableware: A randomized controlled study
Ching-Hsiang Leung, Min-Su Tzeng, Chia-Ying Tsai, Wan-Rong Tsai, Sung-Chen Liu, Pi-Hui Hsu, Shih-Ming Chuang
Primary Care Diabetes.2025; 19(2): 149. CrossRef
Impact of Portion Control Tools on Portion Size Awareness, Choice and Intake: Systematic Review and Meta-Analysis
M. Angeles Vargas-Alvarez, Santiago Navas-Carretero, Luigi Palla, J. Alfredo Martínez, Eva Almiron-Roig
Nutrients.2021; 13(6): 1978. CrossRef
Do adults draw differently-sized meals on larger or smaller plates? Examining plate size in a community sample
David Sharp, Jeffery Sobal, Elaine Wethington
Food Quality and Preference.2019; 74: 72. CrossRef
Use and effectiveness of behavioural economics in interventions for lifestyle risk factors of non-communicable diseases: a systematic review with policy implications
Oana M Blaga, Livia Vasilescu, Razvan M Chereches
Perspectives in Public Health.2018; 138(2): 100. CrossRef
Whether Smaller Plates Reduce Consumption Depends on Who's Serving and Who's Looking: A Meta-Analysis
Stephen S. Holden, Natalina Zlatevska, Chris Dubelaar
SSRN Electronic Journal .2015;[Epub] CrossRef
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco
Gareth J Hollands, Ian Shemilt, Theresa M Marteau, Susan A Jebb, Hannah B Lewis, Yinghui Wei, Julian P T Higgins, David Ogilvie
Cochrane Database of Systematic Reviews.2015;[Epub] CrossRef

Small Rice Bowl-Based Meal Plan versus Food Exchange-Based Meal Plan for Weight, Glucose and Lipid Control in Obese Type 2 Diabetic Patients: Hee-Jung Ahn, Kyung-Ah Han, Hwi-Ryun Kwon, Bo-Kyung Koo, Hyun-Jin Kim, Kang-Seo Park, Kyung-Wan Min; Korean Diabetes J. 2010;34(2):86-94. Published online April 30, 2010; DOI: https://doi.org/10.4093/kdj.2010.34.2.86

7,685 View
39 Download
11 Crossref

Abstract PDF PubReader ePub

Background

The Korean National Health and Nutrition Examination Surveys reported 65% of daily energy intake (EI) as carbohydrate (CHO) in the Korean population and main source of CHO was cooked rice. We used a standardized-small sized rice bowl for diet education and investigated its effectiveness on body weight, glucose and lipid, compared to the conventional food exchange system in type 2 diabetes obese women.

Methods

Type 2 diabetic women with body mass index ≥ 23 kg/m² were randomly assigned to small rice bowl-based meal plan (BM) and food exchange-based meal plan (ExM) group. Both groups were asked to reduce their EI by 500 kcal/day for 12 weeks. The macronutrient composition was instructed: 55 to 60% of EI as CHO, 15 to 20% as protein, and 20 to 25% as fat. BM group received only a simple instruction for application of the rice bowl. Nutrient intake was estimated with the 3-day dietary records.

Results

Finally, 44 subjects finished the study. The percent reduction of body weight was significant both BM group (-5.1 ± 2.6%) and ExM group (-4.8 ± 2.8%) after 12 weeks (P < 0.001) but there was no difference between the groups. There was no difference in the proportional change of CHO, protein and fat in EI between the groups. Additionally, the change of HbA1c and low density lipoprotein-cholesterol were not significantly different between the two groups.

Conclusion

The BM group was as effective as ExM for body weight and glucose control in type 2 diabetes obese women.

Citations

Citations to this article as recorded by

Development of a Sport Food Exchange List for Dietetic Practice in Sport Nutrition
José Miguel Martínez-Sanz, Susana Menal-Puey, Isabel Sospedra, Giuseppe Russolillo, Aurora Norte, Iva Marques-Lopes
Nutrients.2020; 12(8): 2403. CrossRef
The Effect of Combined Therapy with Fenugreek and Nutrition Training Based on Iranian Traditional Medicine on FBS, HgA1c, BMI, and Waist Circumference in Type 2 Diabetic Patients: a Randomized Double Blinded Clinical Trial
Seyyedeh Seddigheh Hassani, Arezodar Fallahi, Seyyed Saeid Esmaeili, Mohammad Gholami Fesharaki
Journal of Advances in Medical and Biomedical Research.2019; 27(120): 37. CrossRef
Establecimiento del tamaño de raciones de consumo de frutas y hortalizas para su uso en guías alimentarias en el entorno español: propuesta del Comité Científico de la Asociación 5 al día
Giuseppe Russolillo, Eduard Baladia, Manuel Moñino, Iva Marques-Lopes, Andreu Farran, Joan Bonany, Victoria Gilabert, Iciar Astiasarán, Maria Dolores Raigón, Alfredo Martínez, Juan Manuel Ballesteros, Francesc Miret, Andreu Palou, María Dolores Romero-de-
Revista Española de Nutrición Humana y Dietética.2019; 23(4): 205. CrossRef
Development of a Spanish Food Exchange List: Application of Statistical Criteria to a Rationale Procedure
Iva Marques-Lopes, Susana Menal-Puey, J. Alfredo Martínez, Giuseppe Russolillo
Journal of the Academy of Nutrition and Dietetics.2018; 118(7): 1161. CrossRef
A Practical Approach to the Management of Micronutrients and Other Nutrients of Concern in Food Exchange Lists for Meal Planning
Giuseppe Russolillo-Femenías, Susana Menal-Puey, J. Alfredo Martínez, Iva Marques-Lopes
Journal of the Academy of Nutrition and Dietetics.2018; 118(11): 2029. CrossRef
Anemia is inversely associated with serum C-peptide concentrations in individuals with type 2 diabetes
Jin Ook Chung, Seon-Young Park, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung
Medicine.2018; 97(32): e11783. CrossRef
Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes
Jin Ook Chung, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung
Journal of Diabetes and its Complications.2015; 29(3): 350. CrossRef
Serum bilirubin concentrations are positively associated with serum C‐peptide levels in patients with Type 2 diabetes
J. O. Chung, D. H. Cho, D. J. Chung, M. Y. Chung
Diabetic Medicine.2014; 31(11): 1316. CrossRef
Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients
Bo-Yeon Kim, Chan-Hee Jung, Ji-Oh Mok, Sung-Koo Kang, Chul-Hee Kim
Acta Diabetologica.2012; 49(1): 9. CrossRef
Small Rice Bowl-Based Meal Plan for Energy and Marcronutrient Intake in Korean Men with Type 2 Diabetes: A Pilot Study
Hee Jung Ahn, Kyung Ah Han, Jin Young Jang, Jae Hyuk Lee, Kang Seo Park, Kyung Wan Min
Diabetes & Metabolism Journal.2011; 35(3): 273. CrossRef
The Small Rice Bowl-Based Meal Plan was Effective at Reducing Dietary Energy Intake, Body Weight, and Blood Glucose Levels in Korean Women with Type 2 Diabetes Mellitus
Hee Jung Ahn, Kyung Ah Han, Hwi Ryun Kwon, Kyung Wan Min
Korean Diabetes Journal.2010; 34(6): 340. CrossRef

Randomized Controlled Trial

The Effects of Low-Calorie Diets on Abdominal Visceral Fat, Muscle Mass, and Dietary Quality in Obese Type 2 Diabetic Subjects.: Hee Jung Ahn, Youn Ok Cho, Hwi Ryun Kwon, Yun Hyi Ku, Bo Kyung Koo, Kyung Ah Han, Kyung Wan Min; Korean Diabetes J. 2009;33(6):526-536. Published online December 1, 2009; DOI: https://doi.org/10.4093/kdj.2009.33.6.526

4,274 View
62 Download
7 Crossref

Abstract PDF

BACKGROUND
Weight loss through low-calorie diets (LCDs) decreases visceral fat (VF). However, the effects on muscle mass, changes of dietary quality, and insulin sensitivity are unknown for Korean obese type 2 diabetic subjects. Therefore, this study examined such effects of LCDs. METHODS: A total of 30 obese type 2 diabetic subjects (body mass index, 27.0 +/- 2.2 kg/m2) were randomly assigned to an LCD or control group. Subjects on LCDs took 500~1,000 kcal fewer energy than their usual dietary intake (1,000~1,500 kcal/day) over the course of 12 weeks. The abdominal VF and femoral muscle mass were evaluated by computed tomography, and insulin sensitivity was assessed using an insulin tolerance test (Kitt; rate constant for plasma glucose disappearance, %/min). Dietary nutrient intake consumed by subjects was assessed by 3-day food records. RESULTS: The percent VF reduction was -23.4 +/- 17.2% in the LCD group and -9.8 +/- 11.8% in the control group after 12 weeks (P < 0.001, P = 0.002). However, significant decrease in femoral mass or proportional change of marcronutrient intake and mean adequacy ratio were not found in the LCD group, as compared to the control group. Insulin sensitivity improved in the LCD group, as compared to the control group (P = 0.040). CONCLUSION: LCD effectively improved insulin sensitivity and reduced abdominal VF without reduction of femoral muscle and dietary quality in obese type 2 diabetic subjects.

Citations

Citations to this article as recorded by

The association between measurement sites of visceral adipose tissue and cardiovascular risk factors after caloric restriction in obese Korean women
Hye-Ok Lee, Jung-Eun Yim, Jeong-Sook Lee, Young-Seol Kim, Ryowon Choue
Nutrition Research and Practice.2013; 7(1): 43. CrossRef
Effects of age on changes of body composition through caloric restriction in overweight and obese women
Jung-Eun Yim, Young-Seol Kim, Ryowon Choue
Journal of Nutrition and Health.2013; 46(5): 410. CrossRef
The effects of weight loss by a low-calorie diet and a low-calorie plus exercise in overweight undergraduate students
Gun-Ae Yoon, Hyun-Ho Ahn, Bo-Hae Park, Danbi Yoo, Sunmin Park
Korean Journal of Nutrition.2012; 45(4): 315. CrossRef
Effect of an abdominal obesity management program on dietary intake, stress index, and waist to hip ratio in abdominally obese women - Focus on comparison of the WHR decrease and WHR increase groups -
Ji Won Lee, Sook Young Yoo, So Young Yang, Hyesook Kim, Seong Kyung Cho
Korean Journal of Nutrition.2012; 45(2): 127. CrossRef
The Evaluation of Workplace Obesity Intervention Program using Six Sigma Methodology
Ji Yeon Kang, Ill Keun Park, Yun Kyun Chang, Sook Hee Sung, Yoo Kyoung Park, Sang Woon Cho, Yun Mi Paek, Tae In Choi
The Korean Journal of Obesity.2011; 20(4): 193. CrossRef
The Usefulness of an Accelerometer for Monitoring Total Energy Expenditure and Its Clinical Application for Predicting Body Weight Changes in Type 2 Diabetic Korean Women
Ji Yeon Jung, Kyung Ah Han, Hwi Ryun Kwon, Hee Jung Ahn, Jae Hyuk Lee, Kang Seo Park, Kyung Wan Min
Korean Diabetes Journal.2010; 34(6): 374. CrossRef
The Effects of Low-Calorie Diets on Abdominal Visceral Fat, Muscle Mass, and Dietary Quality in Obese Type 2 Diabetic Subjects (Korean Diabetes J 2009;33:526-36)
Won-Young Lee
Korean Diabetes Journal.2010; 34(1): 66. CrossRef

Original Article

Prevention of Diabetes by Fenofibrate in OLETF Rats: Hepatic Mechanism for Reducing Visceral Adiposity.: Hye Jeong Lee, Mi Kyoung Park, Kyung Il Lee, Young Jun An, Ji Min Kim, Ja Young Park, Young Han, Sook Hee Hong, Sun Seob Choi, Young Hyun Yoo, Joon Duk Suh, Duk Kyu Kim; Korean Diabetes J. 2007;31(1):63-74. Published online January 1, 2007; DOI: https://doi.org/10.4093/jkda.2007.31.1.63

3,440 View
20 Download
4 Crossref

Abstract PDF

BACKGROUND
The aim of this study is to evaluate the hepatic mechanism of fenofibrate that has the diabetes protective action in rats. METHODS: We chose OLETF rats and divided them into three groups. Fenofibrate (DF) group was fed with diet and fenofibrate (300 mg/kg/day). Paired feeding (Dd) group and free diet (DD) group were fed with diet. After 36 weeks of treatment, all the rats were sacrificed. RESULTS: The fasting blood glucose level of DF group (8.5 +/- 0.9 mmol/L) showed normal. The fasting blood glucose level of Dd group (22.4 +/- 3.0 mmol/L) and DD group (16.9 +/- 3.7 mmol/L) showed significantly increased than that of DF group (P < 0.01, respectively). The body weight, visceral adipose tissue and subcutaneous adipose tissue of DF group were significantly decreased compared to those of Dd and DD groups (P < 0.01, P < 0.05, P < 0.05). DF group showed significantly increased state-3 respiration rate, ATP synthetic activity, state-4 respiration rate and their blood beta-keton body levels than those of control groups (P < 0.01, respectively). DF group showed normal morphology of hepatocytes but DD and Dd groups showed hepatic steatosis with mitochondrial swellings. CONCLUSION: Chronic fenofibrate treatment prevents the development of diabetes in OLETF rats with inhibiting gain of body weight and abdominal adiposity. The hepatic mechanism for reducing visceral adiposity is that fenofibrate leads to increasing oxidative phosphorylation, uncoupling and ketogenesis as well as increasing beta-oxidation of fatty acids. Moreover, fenofibrate treatment prevents the development of hepatic steatosis.

Citations

Citations to this article as recorded by

The Differences of Metabolic Syndrome Risk Factors according to Obesity and Abdominal Obesity in Elderly Korean Women
Kyung-A Shin
The Korean Journal of Clinical Laboratory Science.2016; 48(4): 304. CrossRef
Effects of Soybean and DJI Chungkukjang Powder on Blood Glucose and Serum Lipid Reduction in db/db Mice
Jae-Joon Lee, Ah-Ra Kim, Hae-Choon Chang, Hae-Ok Jung, Myung-Yul Lee
Journal of the Korean Society of Food Science and Nutrition.2012; 41(8): 1086. CrossRef
Comparative analysis of fat and muscle proteins in fenofibratefed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein
Jong-Ryeal Hahm, Jin-Sook Ahn, Hae-Sook Noh, Seon-Mi Baek, Ji-Hye Ha, Tae-Sik Jung, Yong-Jun An, Duk-Kyu Kim, Deok-Ryong Kim
BMB Reports .2010; 43(5): 337. CrossRef
Comparative analysis of fat and muscle proteins in fenofibratefed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein
Jong-Ryeal Hahm, Jin-Sook Ahn, Hae-Sook Noh, Seon-Mi Baek, Ji-Hye Ha, Tae-Sik Jung, Yong-Jun An, Duk-Kyu Kim, Deok-Ryong Kim
BMB Reports.2010; 43(5): 337. CrossRef

First
Prev
Page of 1
Next
Last

Search